Clinical Trials Directory

Trials / Completed

CompletedNCT03970941

Two-stage Treatment of Large Bone Defects With Cerament® G and Cerament® V Plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy After Bone Resection in Patients With Septic Pseudarthrosis

Status
Completed
Phase
Study type
Observational
Enrollment
8 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Septic pseudarthrosis of long bones are complications that can unfortunately occur after the consolidation of a fracture and some situations present risks of superinfection, persistent infection or mechanical failure (30-40% risk of complications) that can lead to amputation. A possible saving situation used by CRIOAC ("Centre de Référence des Infections Ostéo-Articulaires Complexes") is the use of a bone substitute impregnated with an antibiotic allowing a high local concentration of this antibiotic. The aim of this study is to evaluate the cost of management of septic pseudarthrosis with two-stage treatment and CERAMENT® and the quality of life for this patients.

Conditions

Interventions

TypeNameDescription
OTHERCost evaluationThe cost for the hospital of the strategy of management will be evaluated.
OTHERQuestionnaireThe quality of life of patients will be measured.

Timeline

Start date
2019-09-05
Primary completion
2022-12-21
Completion
2022-12-21
First posted
2019-06-03
Last updated
2024-12-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03970941. Inclusion in this directory is not an endorsement.